Qassim University   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Qassim Saudi Arabia (2004)

Organization Overview

First Clinical Trial
2017
NCT06066073
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Assistant Prof. at Pharmaceutics dept., Faculty of Pharmacy, Qassim University, KSA | College of Dentistry, Qassim University, Saudi Arabia | College of medical rehabilitation, Qassim University | Qassim University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Skin Diseases (Phase 1)

Skin Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 12